Showing 2611-2620 of 4166 results for "".
- Genentech: Topline Phase 3 Results Show Vabysmo Improved Vision in People With RVOhttps://modernod.com/news/genentech-topline-phase-3-results-show-vabysmo-improved-vision-in-people-with-rvo/2481199/Genentech announced positive topline results from two global phase 3 studies, BALATON and COMINO, evaluating the first and only bispecific antibody for the eye, Vabysmo (faricimab-svoa), in macular edema due to branch and central retinal vein occlusion (BRVO and CRVO).
- NORA Issues Response to Medical Groups' Joint Guidance of Vision Disorders Following a Concussionhttps://modernod.com/news/nora-response-to-medical-groups-joint-guidance-of-vision-disorders-following-a-concussion/2480978/Below is the response from the Neuro Optometric Rehabilitation Association (NORA) regarding the recent statement from various ophthalmic organizations i
- Genentech: New 2-Year Data Confirm Vabysmo Improves Vision With Fewer Treatments for Wet AMDhttps://modernod.com/news/genentech-new-two-year-data-confirm-vabysmo-improves-vision-with-fewer-treatments-for-people-with-wet-amd/2480965/Genentech announced new 2-year data from the TENAYA and LUCERNE studies that reinforce the long-term efficacy, safety and durability of Vabysmo (faricimab-svoa) in wet age-related macular degeneration (AMD). The 2-year data were presented at the 2022 American Society of Retina Specialis
- Researchers Identify How Multiple Genes Impact Vision Development and Result in Rare Sight Disorderhttps://modernod.com/news/researchers-identify-how-multiple-genes-impact-vision-development-and-result-in-rare-sight-disorder/2480744/
- First UK Patient Receives Bionic Eye Implant to Help Partially Restore Visionhttps://modernod.com/news/first-uk-patient-receives-bionic-eye-implant-to-help-partially-restore-vision/2480601/
- Refractive Surgery Council Reports 32% YTD Increase in Laser Vision Correction Procedure Volume over 2020https://modernod.com/news/refractive-surgery-council-reports-32-ytd-increase-in-laser-vision-correction-procedure-volume-over-2020/2480591/T
- Studies Show Faricimab Improved and Maintained Vision in Wet AMD and DME, Extending Time Between Treatments to 4 Monthshttps://modernod.com/news/the-lancet-publishes-studies-showing-faricimab-improved-and-maintained-vision-in-wet-amd-and-dme-extending-time-between-treatments-to-4-months/2480587/
- Refractive Surgery Council Reports 48% YTD Increase in Laser Vision Correction Procedure Volume Over 2020https://modernod.com/news/refractive-surgery-council-reports-48-ytd-increase-in-laser-vision-correction-procedure-volume-over-2020/2480407/T
- New Essilor Vision Care Center Hosts First Virtual Global Varilux Summit Focused on Presbyopiahttps://modernod.com/news/new-essilor-vision-care-center-hosts-first-virtual-global-varilux-summit-focused-on-presbyopia/2480370/Essilor announced the creation of a digital event platform, the Essilor
- Prevent Blindness: Senate FY2022 Appropriations Bill Doubles Funding for the CDC’s Vision and Eye Health Programhttps://modernod.com/news/prevent-blindness-senate-fy2022-appropriations-bill-doubles-funding-for-the-cdcs-vision-and-eye-health-program/2480364/This week, the Senate Appropriations Committee released its proposed legislation to fund programs under the Department of Health and Human Services in Fiscal Year (FY) 2022. "As a result of continued Prevent Blindness advocacy efforts, the Senate Appropriations legislation includes